THOMPSON KIMBERLY KRAIG (CEO, CFO) reported 1 transaction at KRAIG BIOCRAFT LABORATORIES, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/8/2025ACC: 0001641172-25-003260
DirectorOfficer10% Owner· CEO, CFO
Since Dec 2020
+62.50K
Net shares
Net buyer
$5.7K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
62.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+62.50K
Price / share
$0.09
Trade value
$5.66K
% of position
0.0%
3/31/2025
201.59M→201.65M
Total
Net shares
+62.50K
Net value
$5.66K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/31/2025 | W · W | +62.50K | $0.09 | $5.66K | 0.0% | 201.59M | 201.65M |
| Total | +62.50K | $5.66K | ||||||
Derivative Transactions0
No derivative transactions reported